PMC
Income statement / Annual
Last year (2016), Pharmerica Corporation's total revenue was $2.09 B,
an increase of 3.09% from the previous year.
In 2016, Pharmerica Corporation's net income was $21.60 M.
See Pharmerica Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
FY-2010
|
FY-2009
|
FY-2008
|
FY-2007
|
| Period Ended |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
12/31/2012 |
12/31/2011 |
12/31/2010 |
12/31/2009 |
12/31/2008 |
12/31/2007 |
| Operating Revenue |
$2.09 B |
$2.03 B |
$1.89 B |
$1.76 B |
$1.83 B |
$2.08 B |
$240.00 M |
$1.84 B |
$284.00 M |
$173.00 M |
| Cost of Revenue |
$1.77 B
|
$1.69 B
|
$1.56 B
|
$1.43 B
|
$1.53 B
|
$1.79 B
|
$0.00
|
$1.57 B
|
$0.00
|
$0.00
|
| Gross Profit |
$326.00 M
|
$335.10 M
|
$339.30 M
|
$327.20 M
|
$300.20 M
|
$293.30 M
|
$240.00 M
|
$273.00 M
|
$284.00 M
|
$173.00 M
|
| Gross Profit Ratio |
0.16
|
0.17
|
0.18
|
0.19
|
0.16
|
0.14
|
1
|
0.15
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$220.60 M
|
$222.50 M
|
$236.30 M
|
$225.30 M
|
$214.70 M
|
$214.90 M
|
$180.00 M
|
$187.00 M
|
$214.00 M
|
$141.00 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$220.60 M
|
$222.50 M
|
$236.30 M
|
$225.30 M
|
$214.70 M
|
$214.90 M
|
$180.00 M
|
$187.00 M
|
$214.00 M
|
$141.00 M
|
| Other Expenses |
$33.70 M
|
$28.60 M
|
$20.10 M
|
$15.40 M
|
$12.30 M
|
$11.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$254.30 M
|
$251.10 M
|
$256.40 M
|
$240.70 M
|
$227.00 M
|
$225.90 M
|
$180.00 M
|
$187.00 M
|
$214.00 M
|
$141.00 M
|
| Cost And Expenses |
$2.02 B
|
$1.94 B
|
$1.81 B
|
$1.67 B
|
$1.76 B
|
$2.01 B
|
$180.00 M
|
$1.76 B
|
$214.00 M
|
$141.00 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$9.50 M
|
$6.60 M
|
$9.90 M
|
$10.60 M
|
$10.00 M
|
$8.80 M
|
-$3.00 M
|
-$9.00 M
|
-$14.00 M
|
-$7.00 M
|
| Depreciation & Amortization |
$58.10 M
|
$52.30 M
|
$42.30 M
|
$4.00 M
|
$31.90 M
|
$31.90 M
|
$4.00 M
|
$4.00 M
|
$5.00 M
|
$15.00 M
|
| EBITDA |
$96.50 M |
$106.10 M |
$68.40 M |
$59.80 M |
$80.70 M |
$78.90 M |
$33.00 M |
$55.00 M |
-$1.00 M |
-$29.00 M |
| EBITDA Ratio |
0.05
|
0.05
|
0.04
|
0.03
|
0.04
|
0.04
|
0.14
|
0.03
|
-0
|
-0.17
|
| Operating Income Ratio |
0.02
|
0.03
|
0.02
|
0.03
|
0.03
|
0.02
|
0.13
|
0.04
|
0.03
|
-0.21
|
| Total Other Income/Expenses Net |
-$9.50 M
|
-$6.60 M
|
-$14.20 M
|
-$10.60 M
|
-$10.00 M
|
-$8.80 M
|
$0.00
|
-$9.00 M
|
$0.00
|
$0.00
|
| Income Before Tax |
$28.90 M
|
$47.20 M
|
$16.20 M
|
$45.20 M
|
$38.80 M
|
$38.20 M
|
$32.00 M
|
$61.00 M
|
$8.00 M
|
-$37.00 M
|
| Income Before Tax Ratio |
0.01
|
0.02
|
0.01
|
0.03
|
0.02
|
0.02
|
0.13
|
0.03
|
0.03
|
-0.21
|
| Income Tax Expense |
$7.30 M
|
$12.10 M
|
$9.40 M
|
$26.30 M
|
$15.90 M
|
$14.80 M
|
$13.00 M
|
$18.00 M
|
$3.00 M
|
-$13.00 M
|
| Net Income |
$21.60 M
|
$35.10 M
|
$6.80 M
|
$18.90 M
|
$22.90 M
|
$23.40 M
|
$19.00 M
|
$42.00 M
|
$5.00 M
|
-$24.00 M
|
| Net Income Ratio |
0.01
|
0.02
|
0
|
0.01
|
0.01
|
0.01
|
0.08
|
0.02
|
0.02
|
-0.14
|
| EPS |
0.7 |
1.16 |
0.23 |
0.64 |
0.78 |
0.8 |
0.63 |
1.39 |
0.17 |
-0.13 |
| EPS Diluted |
0.69 |
1.14 |
0.22 |
0.63 |
0.77 |
0.79 |
0.62 |
1.38 |
0.17 |
-0.13 |
| Weighted Average Shares Out |
$30.70 M
|
$30.36 M
|
$29.98 M
|
$29.60 M
|
$29.47 M
|
$29.34 M
|
$30.28 M
|
$30.27 M
|
$30.08 M
|
$184.08 M
|
| Weighted Average Shares Out Diluted |
$31.16 M
|
$30.77 M
|
$30.65 M
|
$30.08 M
|
$29.90 M
|
$29.47 M
|
$30.42 M
|
$30.40 M
|
$30.20 M
|
$184.08 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
